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An efficient, catalyst free, 1,3-dipolar cycloaddition strategy to conjugate nucleosides and nucleotides
with isoxazoles under atmospheric conditions and in an aqueous environment is reported. The protocol
involves chloramine-T as a practical reagent to induce in situ nitrile oxide formation and the alkyne
partner is attached to the sugar residue or the nucleobase. The reactions are regiospecific, fast and high
yielding.
Introduction
In the last 20 years or so non natural nucleic acid and nucleoside
analogues have demonstrated significant clinical value as anti-
cancer and antiviral compounds and many structural variations
involving changes to the nucleobase and, or the ribofuranose
moiety have been explored.1-4 In parallel, the isoxazole ring has
been identified as attractive in terms of its hydrolytic stability, its
potential for p-stacking and H-bonding and due to its sharing
the isosteric character of the amide and ester bond.5,6 It is
well recognised that the activities of different segments within
a molecule can act in concert or confer new attributes on the
molecule, and in this context the synthesis and bioactivity of
isoxazole, isoxazoline and isoxazolidine modified nucleosides has
received much attention. Several families of analogues have been
explored, many involve heterocyclic replacement of the nucleoside
ribose7-11 whilst others fall into the class ofC5-modified pyrimidine
nucleoside drugs,12,13 and others examine the influence of an
N3-tethered heterocycle,8,14 finally, isoxazoles have been introduced
both directly and remotely to the 4¢-ribose carbon.15,16 Two
significant nucleoside derivatives include theN1-tethered isoxazole
1 which has potent activity against the Polio virus7 and the
N3-ligated isoxazoline 2 which displays potent anti-HIV activity.14
Further interesting applications of heterocyclic modifications
within nucleotide and oligonucleotide chemistry include isoxazole
or isoxazoline replacement of the nucleotide phosphodiester
linkage17,18 and the recently reported nitrile oxide click modifica-
tion of DNA by cycloaddition to alkynes19 and strained alkenes.20
In this context we wish to report an efficient synthetic approach
to the preparation of sugar (C3¢-O-) and nucleobase (N3-) tethered
isoxazole thymidines. The key reaction, a nitrile oxide–alkyne
click cycloaddition, proceeds selectively and in high yield under
mild reaction conditions. That the protocol is free from copper
is significant for broader applications as it removes the need
to manage potentially problematic redox interference chemistry;
thus, it presents a complementary approach to the azide–alkyne
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cycloaddition which has been highly successful in generation of
nucleoside, nucleotide and oligonucleotide conjugates.21
The preparation of isoxazole modified nucleosides by selection
of an isoxazole carboxylic acid as one component of the Ugi
reaction16 or by cyclisation approaches22 represents alternatives
to the commonly employed 1,3-dipolar cycloaddition route. The
latter approach has been demonstrated with the nucleoside
bearing either the alkyne moiety or the nitrile oxide precursor;
both ribose15,17 and nucleobase13 modified oximes have served as
nitrile oxide precursors, whilst the alkyne functionality is more
commonly found on the base unit7,8,12 than on the sugar.22 In the
reports to date NaOCl, NCS or NBS have been selected as the
dipole generating agents, generally the reactions are of 10–24 h
duration and yields vary from fair to good. In one recent example
a solid phase approach was demonstrated,8 thoughmore generally
the cycloadditions are reported in solution with THF or CH2Cl2
as reaction solvent.
We have recently shown solid phase nitrile oxide click cycload-
dition chemistry to be successful for the preparation of isoxazole
modifiedDNA19 and for generating 2¢-OMe ribonucleoside and ri-
bonucleotide analogues by [3+2]-cycloaddition to 2¢-O-propargyl
substrates.23 In this paper we further demonstrate the utility of
this reaction in the solution phase synthesis of sugar (C3¢-O) and
nucleobase (N3-) tethered isoxazoles.
Results and discussion
Nucleoside chemistry is delicate due to the numerous reactive
sites and the first step in the synthetic sequence required selective
protection of the 5¢-OH of thymidine, thus, the already known 424
was prepared from thymidine 3 in good yield. Introduction of the
C3¢-O-propargyl group proceeded by nucleophilic displacement.
Propargyl bromide was selected as the alkylating agent and NaH
as the base. It was necessary to exercise caution during the addition
of the bromide and, to ensure regioselective formation of 5, a
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Scheme 1
solution of this reagent in THF was added dropwise at 0 ◦C;
without this precaution the C3¢-O, N3-bisalkylated product 6 was
found as a side product, Scheme 1.Most of the antiviral nucleoside
analogues have 5¢-hydroxyl groups for kinase phosphorylation,
however, some 5¢-tritylated derivatives have demonstrated inhibi-
tion of thymidine phosphorylase and angiogenesis.25 Thus, it was
deemed important to explore the cycloaddition reaction with the
5¢-OH group both protected and unprotected, accordingly, DCA
(dichloroacetic acid) mediated detritylation of 5 furnished the
known 7.26
With the desired thymidine dipolarophiles 5 and 7 to hand the
concept that chloramine-Tmediated nitrile oxide–alkyne cycload-
dition chemistry offers a tool to prepare nucleoside derivatives
was tested. Aromatic appendages are interesting for biological
activity, accordingly benzaldehyde oxime and 1-naphthaldehyde
oxime were selected as the nitrile oxide precursors. The choice of
chloramine-T as the dipole generating agent27 facilitates a move
away from CH2Cl2 or THF and aqueous ethanolic NaHCO3
was the solvent of choice. The 5¢-protected thymidine 5 was
first examined. The reaction components were simply mixed
together in aqueous ethanolic sodiumhydrogen carbonate at room
temperature. The reaction was very fast, reaching completion
simply upon stirring for 1 h under atmospheric conditions and
following purification 8 and 9 were isolated in 96% and 94%
yield respectively. The reaction was equally successful with the
5¢-deprotected substrate 7, and the adducts from cycloaddition
to benzonitrile oxide and 1-naphthonitrile oxide, 10 and 11
respectively, were both obtained in 88%, Scheme 1.
The structural elucidation of the cycloadducts was made on the
basis of their NMR spectra. In all four cases an examination
of the 1H NMR spectra of the crude reaction products was
suggestive of a high yielding, regiospecific formation of a 3,5-
disubstituted isoxazole. A singlet resonance in the region 6.52–
6.62 ppm, diagnostic for the 4-H proton of the isoxazole ring,
confirms the regiochemistry of the reaction; the expected position
for the regioisomeric 3,4-disubstituted isoxazole would be ~1 ppm
further downfield.28 The regioselectivity of the reaction is also
supported by the presence of only one signal representing the
OCH2-isoxazole methylene protons. These protons present as
AB doublets at ~4.6 ppm whilst in the starting propargylated
thymidines the corresponding protons appeared ~0.5 ppm upfield
as part of a multiplet signal together with the resonance of the
4¢-proton.
The C3¢-O-,N3-bispropargyl modified thymidine 6was prepared
in good yield from 4 following deprotonation with NaH (6 eq.)
and alkylation with propargyl bromide (3 eq.). The successful
formation of the diynyl nucleoside was evident from the ap-
pearance of two triplet resonances in the 1H NMR spectrum
at 2.41 and 2.17 ppm, diagnostic of the inequivalent alkyne
protons; the adjacent methylene protons appeared as doublets
at 4.25 (OCH2) and 4.77 (NCH2) ppm respectively. Both the 5¢-
tritylated diynyl 6 and its 5¢-hydroxy parent 12 succumbed to the
nitrile oxide click cycloaddition protocol described above. Thus,
the aryl nitrile oxides generated from reaction of benzaldehyde
oxime or 1-naphthaldehyde oxime with chloramine-T reacted,
in turn, with 6 or 12 under atmospheric conditions, at ambient
temperature in ethanolic sodium hydrogen carbonate. No com-
promise in regioselectivity was noted in formation of the double
cycloaddition products 13 through 16 which were isolated in 78–
87% yield, Scheme 2. Once again 1H NMR spectral evidence
supports formation of the 3,5-disubstituted isoxazoles; in all cases,
concomitant with cycloaddition was the disappearance of the
alkyne proton resonances and a downfield shift (~0.5 ppm) in the
position of the both the NCH2 and the OCH2methylene protons.
No other regioisomer could be found amongst the crude products.
To show compatibility with the nucleotide phosphodiester
backbone 20 was prepared by coupling of the alkynyl alcohol 1719
to the 5¢-Dmt protected thymidine phosphoramidite 18. Following
oxidation and work-up, the protecting group was removed from
19 by treatment with DCA and 20 was obtained in 53% yield
over the two steps, Scheme 3. Analysis by 31P, 13C and 1H NMR
spectroscopy together with HRMS data confirmed the expected
392 | Org. Biomol. Chem., 2010, 8, 391–397 This journal is © The Royal Society of Chemistry 2010
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Scheme 2
structure. In particular a resonance at d -2.6 ppm is diagnostic for
the P(V) nucleus; proton and 13C assignments were supported by
2D-COSY experiments.
The nucleotide 20 subjected to the cycloaddition protocol
under the same conditions as described above for the nucleoside
substrates. Thus the phenyl and naphthyl substituted isoxazole
derivitized nucleotides 21 and 22 were obtained in 77% and 72%
yield respectively following reaction with the appropriate oxime
and chloramine-T in ethanolic NaHCO3 (rt, 1 h), Scheme 3.
Characterisation of the cycloadducts was made on the basis of
their NMR spectral data. In both cases a singlet resonance in
the region 6.58–6.59 ppm, diagnostic for the 4-H proton of the
isoxazole ring confirms formation of a 3,5-disubstituted isoxazole,
further confirmation of the regiochemistry of the reaction is
supported by the appearance of the OCH2 isoxazole protons as
AB doublets at ~4.7 ppm.
Conclusion
In conclusion nitrile oxide–alkyne click cycloaddition chemistry
offers a robust route to novel isoxazole conjugated nucleosides
or nucleotides with either 5¢-trityl protection or with a free
5¢-OH available for additional structural elaboration. The ability
to incorporate an isoxazole nucleus in the design of new thymidine
receptor agonists is potentially very valuable and the significance
of the current work lies in the demonstration of a high yielding
chloramine-T protocol for rapid, catalyst free nucleoside and
nucleotide elaboration under very mild conditions viz room
Scheme 3
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temperature, atmospheric conditions and an aqueous environ-
ment. The synthetic utility of the nitrile oxide reaction, which
reaches completion in 60 min at rt, compares favourably with
the observed copper catalysed formation of triazole linked
dithymidines whichwhilst complete within 3min undermicrowave
activation (80 ◦C, 300 W),29 requires 24 h to reach ~40%
completion at rt.30
Experimental
Analytical TLC was performed on precoated (250 mm) silica gel
60 F-254 plates from Merck. All plates were visualized by UV
irradiation, and/or staining with 5% H2SO4 in ethanol, followed
by heating. Flash chromatography grade silica gel 60 (230-400
mesh) was obtained from Merck. Mass analysis was performed
on a LC/TOF-MS instrument. The LC was a model 1200 Series
(Agilent Corp, Santa Clara, CA), injection volume was 10 mL,
the column was an Agilent Eclipse XBD-C18 (Agilent), 5-micron
with a mobile phase of A = ACN with 0.1% formic acid and
B = 0.1% formic acid in water. The gradient was 5% to 100%
A over 15 min at a flow rate of 0.5 mL min-1. The LC/TOF-
MS was a model 6210 Time-Of-Flight LC/MS (Agilent Corp,
SantaClara, CA)with an electrospray source positive and negative
(ESI ±), capilary 3,500 V, nebuliser spray 30 psig, drying gas
5 L min-1, source temperature 325 ◦C. The fragmentor was used
at 175 V. Reference masses (Agilent solution) were 121.050873,
149.02332, 322.048121, 922.009798, 1221.990633, 1521.971475,
and 2421.91399 m/z. The NMR spectra were obtained for 1H
at 300 MHz, for 13C at 75 MHz and for 31P at 121 MHz on a
Bruker instrument at 25 ◦C.All samples forNMRwere prepared in
CDCl3. Chemical shifts are reported in ppm downfield from TMS
as standard and coupling constants are reported in hertz.Chemical
agents were purchased from Aldrich Chemical Company unless
otherwise noted.
3¢-O-(2-Propynyl)-5¢-O-(triphenylmethyl)thymidine 5
To a solution of 5¢-O-trityl-3¢-O-propargylthymidine 4 (100 mg,
0.206 mmol) in anhydrous THF (4 mL) at 0 ◦C was added slowly,
under argon, anhydrous sodium hydride (13 mg, 0.516 mmol)
and the mixture was stirred at RT for 1 h. The reaction mixture
was cooled to 0 ◦C prior to the addition, drop by drop, of a
solution of propargyl bromide (0.206 mmol) in THF (1 mL).
The mixture was allowed to slowly warm to RT and stirred for
a further 17 h. The reaction was quenched by addition of water.
The product was isolated following extraction with ethyl acetate.
The organic layer was dried over anhydrous sodium sulfate and the
solvent was removed under reduced pressure. The crude product
was purified by flash column chromatography over silica gel using
dichloromethane and acetone (95 : 5) as eluant to give the title
compound as an off-white foam (93%).
Rf 0.31 (DCM,Acetone, 95 : 5); 1HNMR: d 8.88 (1H, br s,NH),
7.58 (1H, s, H6), 7.50–7.18 (15H, m, Ph), 6.37–6.30 (1H, m, H1¢),
4.56–4.49 (1H, m, H3¢), 4.19–4.11 (3H, m, H4¢, OCH2), 3.47 (1H,
dd, 2J 10.6, 3J 3.0, H5¢), 3.38 (1H, dd, 2J 10.6, 3J 3.0, H5¢), 2.58–
2.47 (1H, m, H2¢), 2.41 (1H, t, 4J 2.4, C≡CH), 2.29–2.19 (1H, m,
H2¢), 1.49 (3H, s, CH3); 13C NMR: d 163.7 (C2), 150.3 (C4), 143.4
(ArC), 135.4 (C6), 128.7 (ArC), 128.1 (ArC), 127.4 (ArC), 111.2
(C5), 87.5 (CPh3), 84.8 (C1¢), 83.8 (C4¢), 79.1 (C≡CH), 78.5 (C3¢),
75.1 (CH≡C), 63.6 (C5¢), 53.4 (OCH2), 37.8 (C2¢), 11.9 (CH3);
HRMS (ESI): m/z C32H30N2NaO5 requires 545.2047 [M+Na]+,
found 545.2052 (0.96 ppm).
General procedure for the nitrile oxide–alkyne cycloaddition
To a round bottomed flask containing the oxime (2 eq. for the
monoalkynes 5, 7 and 19 or 3 eq. for the bisalkynes 6 and 12) and
chloramine-T monohydrate (2.5 eq. for the mono- or 3.5 eq. for
the bisalkynes) in 4% aqueous sodium hydrogen carbonate (2 mL
per 0.1 mmol of oxime) and ethanol (1 mL per 0.1 mmol oxime)
was added the propargylated thymidine. The mixture was stirred
for 1 h at RT after which analysis by TLC indicated complete
reaction. The product was isolated following extraction with ethyl
acetate. The organic layerwas dried over anhydrous sodium sulfate
and the solvent was removed under reduced pressure to afford the
crude products which were purified as described below.
3¢-O-[(3-Phenylisoxazol-5-yl)methyl]-5¢-O-
(triphenylmethyl)thymidine 8
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane and acetone (97 : 3),
to give the title compound as an off-white solid, (96%).
Rf 0.46 (DCM,Acetone, 95 : 5); 1HNMR: d 8.78 (1H, br s, NH),
7.83–7.18 (21H, m, H6, Ph), 6.52 (1H, s, CH=CO iso), 6.41–6.34
(1H, m, H1¢), 4.65 (1H, d, 2J 13.9, OCH2), 4.58 (1H, d, 2J 13.9,
OCH2), 4.38–4.32 (1H, m, H3¢), 4.21–4.16 (1H, m, H4¢), 3.50 (1H,
dd, 2J 10.6, 3J 3.3, H5¢), 3.35 (1H, dd, 2J 10.6, 3J 2.7, H5¢), 2.59–
2.49 (1H, m, H2¢), 2.31–2.18 (1H, m, H2¢), 1.52 (3H, s, CH3); 13C
NMR: d 169.0 (C=N iso), 163.7 (C2), 162.5 (CO=CH iso), 150.3
(C4), 143.2 (ArC), 135.3 (C6), 130.2 (ArC), 129.0 (ArC), 128.7
(ArC), 128.6 (ArC), 128.1 (ArC), 127.5 (ArC), 126.9 (ArC), 111.4
(C5), 101.3 (CH=CO iso), 87.6 (CPh3), 84.8 (C1¢), 83.8 (C4¢), 80.1
(C3¢), 63.8 (C5¢), 62.2 (OCH2), 37.8 (C2¢), 11.9 (CH3); HRMS (ESI):
m/z C39H35N3NaO6 requires 664.2418 [M+Na]+, found 664.2398
(-3.07 ppm).
3¢-O-[3-[(1-Naphthyl)isoxazol-5-yl]methyl]-5¢-O-
(triphenylmethyl)thymidine 9
The crude product was purified by flash column chromatography
over silica gel using dichloromethane and acetone (95 : 5) as eluant
to give the title compound as an off-white solid (94%).
Rf 0.21 (DCM, Acetone, 95 : 5); 1H NMR: d 8.41 (1H, br s,
NH), 8.38–7.17 (23H, m, H6, Ph, Naph), 6.53 (1H, s, CH=CO
iso), 6.42–6.35 (1H, m, H1¢), 4.73 (1H, d, 2J 13.6, OCH2), 4.65
(1H, d, 2J 13.6, OCH2), 4.45–4.38 (1H, m, H3¢), 4.24–4.17 (1H,
m, H4¢), 3.52 (1H, dd, 2J 10.7, 3J 3.3, H5¢), 3.37 (1H, dd, 2J 10.6,
3J 3.0, H5¢), 2.65–2.51 (1H, m, H2¢), 2.34–2.21 (1H, m, H2¢), 1.52
(3H, s, CH3); 13C NMR: d 168.3 (C=N iso), 163.4 (C2), 162.6
(CO=CH iso), 150.2 (C4), 143.2 (ArC), 135.3 (C6), [133.8, 130.9,
130.4, 128.6, 128.5, 128.1, 127.9, 127.5, 127.1, 126.5, 126.3, 125.6,
125.2] (ArC), 111.3 (C5), 104.6 (CH=CO iso), 87.6 (CPh3), 84.8
(C1¢), 83.8 (C4¢), 80.2 (C3¢), 63.8 (C5¢), 62.3 (OCH2), 37.9 (C2¢), 11.9
(CH3); HRMS (ESI):m/zC43H38N3O6 requires 692.2755 [M+H]+,
found 692.2741 (-2.1 ppm).
394 | Org. Biomol. Chem., 2010, 8, 391–397 This journal is © The Royal Society of Chemistry 2010
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General procedure for deprotection of 5¢-trityl thymidine derivatives
The tritylated thymidine was stirred for 0.5 h at RT in a solution of
DCA 3.5% in DCM (1 mL/0.1 mmol). The reaction mixture was
washed with a saturated solution of sodium hydrogen carbonate
until the aqueous layer became neutral. The organic layer was
dried over anhydrous sodium sulfate and the solvent was removed
under reduced pressure to afford the crude products which were
purified as described below.
3¢-O-(2-Propynyl)thymidine 725
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane and methanol (0 to
5%), to give the title compound as an off-white foam (96%).
Rf 0.18 (DCM, MeOH, 95 : 5); 1H NMR: d 9.45 (1H, br s, NH),
7.44 (1H, s, H6), 6.12 (1H, t, 3J 6.6, H1¢), 4.46–4.38 (1H, m, H3¢),
4.29–4.09 (3H, m, H4¢, OCH2), 3.95 (1H, dd, 2J 12.1, 3J 2.7, H5¢),
3.82 (1H, dd, 2J 12.1, 3J 3.0, H5¢), 3.58 (1H, br s, OH), 2.49
(1H, t, 4J 2.4, C≡CH), 2.46-2.30 (2H, m, H2¢), 1.90 (3H, s, CH3);
HRMS (ESI): m/z C13H16N2NaO5 requires 280.1148 [M+Na]+,
found 280.1178 (2.61 ppm).
3¢-O-[(3-Phenylisoxazol-5-yl)methyl]thymidine 10
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane andmethanol (95 : 5),
to give the title compound as an off-white solid (88%).
1H NMR: d 8.55 (1H, br s, NH), 7.81–7.78 (2H, m, ArH),
7.46–7.44 (3H, m, ArH), 7.38 (1H, s, H6), 6.59 (1H, s, CH=CO
iso)), 6.13 (1H, t, J 7.2, H1¢), 4.72 (1H, d, 2J 13.8, OCH2), 4.66
(1H, d, 2J 13.8, OCH2), 4.40–4.37 (1H, m, H3¢), 4.15 (1H d, J
2.7, H4¢), 3.92 (1H dd, 2J 11.7, 3J 2.7, H5¢), 3.80 (1H dd, 2J
11.7, 3J 3.0, H5¢), 2.41–2.37 (2H, m, H2¢), 1.89 (3H, s, CH3); 13C
NMR: d 170.0 (C=N iso), 163.3 (C2), 162.1 (CO=CH iso), 150.5
(C4), 136.0 (C6), 130.0–126.6 (ArH), 109.9 (C5), 101.2 (CH=CO
iso), 85.0 (C1¢), 85.8 (C4¢), 80.3 (C3¢), 62.1 (C5¢), 61.7 (OCH2), 36.9
(C2¢), 11.6 (CH3);HRMS(ESI):m/zC20H22N3O6 requires 400.1509
[M+Na]+, found 400.1494 (1.16 ppm).
3¢-O-[3-[(1-Naphthyl)isoxazol-5-yl]methyl]thymidine 11
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane andmethanol (95 : 5),
to give the title compound as an off-white solid (88%).
Rf 0.24 (DCM, MeOH, 95 : 5); 1H NMR: d 8.39–8.32 (1H, m,
ArH), 7.99–7.89 (2H, m, ArH), 7.72–7.67 (1H, m, ArH), 7.60–
7.50 (3H, m, ArH), 7.38 (1H, s, H6), 6.62 (1H, s, CH=CO iso),
6.14 (1H, t, 3J 9.9, H1¢), 4.78 (1H, d, 2J 13.9, OCH2), 4.73 (1H,
d, 2J 13.9, OCH2), 4.49–4.41 (1H, m, H3¢), 4.23–4.16 (1H, m,
H4¢), 3.96 (1H, dd, 2J 12.5, 3J 3.3, H5¢), 3.83 (1H, dd, 2J 12.4, 3J
2.7, H5¢), 2.49–2.40 (2H, m, H2¢), 1.92 (3H, s, CH3); 13C NMR: d
168.3 (C=N iso), 163.5 (C2), 162.7 (CO=CH iso), 150.3 (C4), 137.0
(C6), [133.8, 130.9, 130.4, 128.6, 127.9, 127.2, 126.4, 125.5, 125.2]
(ArC), 111.4 (C5), 104.8 (CH=CO iso), 87.5 (C1¢), 85.0 (C4¢), 80.0
(C3¢), 62.7 (C5¢), 62.5 (OCH2), 37.0 (C2¢), 12.5 (CH3); HRMS (ESI):
m/z C24H23KN3O6 requires 488.1218 [M+K]+, found 488.1221
(0.58 ppm).
3-(2-Propynyl)-3¢-O-(2-propynyl)-5¢-O-
(triphenylmethyl)thymidine 6
To a solution of 5¢-O-trityl-3¢-O-propargylthymidine 4 (195 mg,
0.402 mmol) in anhydrous THF (4 mL) at 0 ◦C was added slowly,
under argon, anhydrous sodium hydride (58 mg, 2.415 mmol) and
themixture was stirred at RT for 1 h. Propargyl bromide (1.40mL,
1.335 mmol) was added drop by drop and the mixture was stirred
for 17 h at RT. The reaction was quenched by addition of water.
The product was isolated following extraction with ethyl acetate.
The organic layer was dried over anhydrous sodium sulfate and the
solvent was removed under reduced pressure. The crude product
was purified by flash column chromatography over silica gel using
dichloromethane and acetone (0 to 2%) as eluant to give the title
compound as an off-white foam (77%).
Rf 0.58 (DCM, Acetone, 98 : 2); 1H NMR: d 7.62 (1H, s, H6),
7.50–7.20 (15H,m, Ph), 6.42–6.34 (1H,m,H1¢), 4.77 (2H, d, 4J 2.4,
NCH2), 4.58–4.49 (1H, m, H3¢), 4.25–4.07 (3H, m, H4¢, OCH2),
3.47 (1H, dd, 2J 10.7, 3J 3.0, H5¢), 3.38 (1H, dd, 2J 10.7, 3J 3.0,
H5¢), 2.61–2.50 (1H, m, H2¢), 2.41 (1H, t, 4J 2.4, OCH2C≡CH),
2.32–2.19 (1H, m, H2¢), 2.17 (1H, t, 4J 2.4, NCH2C≡CH), 1.51
(3H, s, CH3);13CNMR: d 162.5 (C2), 150.2 (C4), 143.3 (ArC), 133.9
(C6), [128.7, 128.9, 128.7, 128.1, 127.9, 127.5, 127.1] (ArC), 110.1
(C5), 87.5 (CPh3), 85.5 (C1¢), 83.8 (C4¢), 79.1 (OCH2C≡CH), 78.3
(NCH2C≡CH, C3¢), 75.1 (OCH2C≡CH), 70.6 (NCH2C≡CH),
63.6 (C5¢), 56.7 (OCH2), 37.9 (C2¢), 30.4 (NCH2),12.6 (CH3);
HRMS (ESI): m/z C35H33N2O5 requires 561.2384 [M+H]+, found
561.2402 (3.23 ppm).
3-[(3-Phenylisoxazol-5-yl)methyl]-3¢-O-[(3-phenylisoxazol-5-
yl)methyl]-5¢-O-(triphenylmethyl)thymidine 13
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane and acetone (0 to
2%), to give the title compound as an off-white solid (87%).
Rf 0.70 (DCM, Acetone, 98 : 2); 1H NMR: d 7.81–7.73 (5H, m,
ArH), 7.62 (1H, s, H6), 7.49–7.20 (20H, m, ArH), 6.57 (1H, s,
CH=CO iso), 6.51 (1H, s, CH=CO iso), 6.44–6.37 (1H, m, H1¢),
5.31 (2H, m, NCH2), 4.65 (1H, d, 2J 13.6, OCH2), 4.58 (1H, d, 2J
13.6, OCH2), 4.40–4.33 (1H, m, H3¢), 4.21–4.15 (1H, m, H4¢), 3.51
(1H, dd, 2J 10.9, 3J 3.3, H5¢), 3.35 (1H, dd, 2J 10.7, 3J 2.7, H5¢),
2.61–2.52 (1H, m, H2¢), 2.32–2.20 (1H, m, H2¢), 1.54 (3H, s, CH3);
13C NMR: d 169.0 (C=N iso), 167.7 (C=N iso), 162.7 (C2), 162.5
(2 ¥ CO=CH iso), 150.5 (C4), 143.2 (ArC), 134.0 (C6), [130.2,
129.3, 129.0, 128.8, 128.7, 128.6, 128.1, 127.5, 126.9] (ArC), 110.6
(C5), 101.3 (2 ¥ CH=CO iso), 87.6 (CPh3), 85.6 (C1¢), 83.9 (C4¢),
80.0 (C3¢), 63.7 (C5¢), 62.3 (OCH2), 38.0 (C2¢), 36.2 (NCH2), 12.6
(CH3); HRMS (ESI): m/z C49H42N4O7 requires 798.3048 [M*]+,
found 798.3105 (7.16 ppm).
3-[3-[(Naphthyl)isoxazol-5-yl]methyl]-3¢-O-[3-[(naphthyl)isoxazol-
5-yl]methyl]-5¢-O-(triphenylmethyl)thymidine 14
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane and acetone (0 to
2%), to give the title compound as an off-white solid (86%).
Rf 0.58 (DCM, Acetone, 98 : 2); 1H NMR: d 8.43–8.29 (2H, m,
ArH), 7.99–7.84 (4H,m,ArH), 7.70–7.17 (24H,m,H6,ArH), 6.59
(1H, s, CH=CO iso), 6.52 (1H, s, CH=CO iso), 6.49–6.42 (1H,
m, H1¢), 5.38 (2H, s, NCH2), 4.72 (1H, d, 2J 13.4, OCH2), 4.64
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 391–397 | 395
D
ow
nl
oa
de
d 
by
 N
U
I M
ay
no
ot
h 
on
 0
9/
04
/2
01
3 
14
:1
2:
34
. 
Pu
bl
ish
ed
 o
n 
28
 O
ct
ob
er
 2
00
9 
on
 h
ttp
://
pu
bs
.rs
c.o
rg
 | d
oi:
10.
103
9/B
917
450
H
View Article Online
(1H, d, 2J 13.4, OCH2), 4.49–4.39 (1H, m, H3¢), 4.26–4.18 (1H,
m, H4¢), 3.54 (1H, dd, 2J 10.7, 3J 3.0, H5¢), 3.38 (1H, dd, 2J 10.7,
3J 2.7, H5¢), 2.67–2.56 (1H, m, H2¢), 2.38–2.26 (1H, m, H2¢), 1.56
(3H, s, CH3); 13CNMR: d 168.3 (C=N iso), 167.1 (C=N iso), 162.7
(C2), 162.6 (2 ¥ CO=CH iso), 150.5 (C4), 143.3 (ArC), 134.1 (C6),
[133.8, 131.0, 113.4, 130.2, 128.8, 128.6, 128.5, 128.4, 128.1, 127.9,
127.5, 127.2, 127.0, 126.8, 126.5, 126.4, 126.2, 125.8, 125.6, 125.2,
125.1] (ArC), 110.6 (C5), 104.7 (2 ¥ CH=CO iso), 87.6 (CPh3), 85.6
(C1¢), 83.9 (C4¢), 80.1 (C3¢), 63.7 (C5¢), 62.3 (OCH2), 38.0 (C2¢), 36.4
(NCH2), 12.6 (CH3); HRMS (ESI): m/z C57H46N4NaO7 requires
921.3259 [M+Na]+, found 921.3282 (2.52 ppm).
3-(2-Propynyl)-3¢-O-(2-propynyl)thymidine 12
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane and methanol (0 to
5%), to give the title compound as a off-white foam (94%).
Rf 0.39 (DCM, MeOH, 95 : 5); 1H NMR: d 7.43 (1H, s, H6),
6.14 (1H, t, 3J 7.5, H1¢), 4.72 (2H, d, 4J 2.4, NCH2), 4.47–4.40
(1H, m, H3¢), 4.28–4.05 (4H, m, H4, OCH2, OH), 3.97 (1H,
dd, 2J 12.5, 3J 2.7, H5¢), 3.85 (1H, dd, 2J 12.5, 3J 3.0, H5¢),
2.49 (1H, t, 4J 2.4, OCH2C≡CH), 2.47–2.36 (2H, m, H2¢), 2.17
(1H, t, 4J 2.4, NCH2C≡CH), 1.96 (3H, s, CH3);13C NMR: d
162.6 (C2), 150.2 (C4), 135.5 (C6), 110.5 (C5), 88.0 (C1¢), 84.9
(C4¢), 79.1 (OCH2C≡CH), 78.4 (C3¢), 78.0 (NCH2C≡CH), 75.2
(OCH2C≡CH), 70.8 (NCH2C≡CH), 62.6 (C5¢), 56.9 (OCH2), 38.0
(C2¢), 30.5 (NCH2),13.2 (CH3); HRMS (ESI): m/z C16H18KN2O5
requires 357.0847 [M+K]+, found 357.0853 (1.46 ppm).
3-[(3-Phenylisoxazol-5-yl)methyl]-3¢-O-[(3-phenylisoxazol-5-
yl)methyl]thymidine 15
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane andmethanol (98 : 2),
to give the title compound as an off-white solid (80%).
Rf 0.35 (DCM, MeOH, 98 : 2); 1H NMR: d 7.78–7.64 (4H, m,
ArH), 7.44–7.28 (7H, m, H6, ArH), 6.52 (1H, s, CH=CO iso),
6.49 (1H, s, CH=CO iso), 6.11 (1H, t, 3J 7.7, H1¢), 5.22 (2H, s,
NCH2), 4.63 (1H, d, 2J 13.4, OCH2), 4.58 (1H, d, 2J 13.4, OCH2),
4.36–4.28 (1H, m, H3¢), 4.12–4.06 (1H, m, H4¢), 3.88 (1H, dd,
2J 11.6, 3J 2.4, H5¢), 3.74 (1H, br d, 2J 11.5, H5¢), 2.52–2.25
(3H, m, H2¢, OH), 1.88 (3H, s, CH3); 13C NMR: d 168.0 (C=N
iso), 166.6 (C=N iso), 161.6 (C2), 161.5 (2 ¥ CO=CH iso), 149.5
(C4), 134.3 (C6), [129.2, 129.0, 128.1, 128.0, 127.9, 127.8, 127.7,
127.6, 127.3, 127.2, 126.5, 126.1, 125.8] (ArC), 109.4 (C5), 100.6
(CH=CO iso), 100.4 (CH=CO iso), 86.8 (C1¢), 84.0 (C4¢), 78.7
(C3¢), 61.7 (C5¢), 61.4 (OCH2), 36.2 (C2¢), 35.2 (NCH2), 12.2 (CH3);
HRMS (ESI): m/z C30H29N4O7 requires 557.2031 [M+H]+, found
557.2051 (3.71 ppm).
3-[3-[(Naphthyl)isoxazol-5-yl]methyl]-3¢-O-[3-[(naphthyl)isoxazol-
5-yl]methyl]thymidine 16
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane and acetone (9 : 1),
to give the title compound as an off-white solid (78%).
Rf 0.44 (DCM, MeOH, 95 : 5); 1H NMR: d 8.40–8.31 (2H, m,
ArH), 7.99–7.83 (4H, m, ArH), 7.73–7.44 (9H, m, H6, ArH), 6.60
(1H, s, CH=CO iso), 6.58 (1H, s, CH=CO iso), 6.26–6.19 (1H,
m, H1¢), 5.37 (2H, s, NCH2), 4.76 (1H, d, 2J 13.6, OCH2), 4.70
(1H, d, 2J 13.6, OCH2), 4.48–4.39 (1H, m, H3¢), 4.22–4.14 (1H,
m, H4¢), 3.79–3.40 (2H, m, H5¢), 2.68 (1H, s, OH), 2.54–2.33 (2H,
m, H2¢), 1.95 (3H, s, CH3); 13C NMR: d 168.3 (C=N iso), 167.0
(C=N iso), 162.7 (C2), 150.6 (C4), 135.4 (2 ¥ CO=CH iso), 133.8
(C6), [131.0, 130.4, 130.2, 128.6, 128.4, 127.8, 127.2, 127.0, 126.7,
126.4, 126.2, 125.7, 125.5, 125.2, 125.1] (ArC), 110.4 (C5), 104.8
(CH=CO iso), 104.7 (CH=CO iso), 87.8 (C1¢), 85.0 (C4¢), 79.9
(C3¢), 67.9 (C5¢), 62.5 (OCH2), 37.3 (C2¢), 36.3 (NCH2), 13.2 (CH3);
HRMS (ESI): m/z C38H33N4O7 requires 658.2375 [M+H]+, found
658.2388 (1.84 ppm).
3¢-Thymidylic acid, 2-cyanoethyl 4-(2-propynyl-1-yloxy)butyl
ester 20
To a round bottom flask containing a solution of alkynyl alcohol
1719 (72 mg, 0.562 mmol) in dry acetonitrile (10 mL) was added,
under argon, BMT (BMT = 5-benzylmercaptotetrazole, 215 mg,
1.119 mmol) followed by dT-CE phosphoramidite 18 (500 mg,
0.671 mmol). The mixture was stirred for 0.5 h at RT after
which analysis by TLC (hexane–EtOAc, 1 : 1) indicated complete
reaction. The mixture was cooled to 0 ◦C in order to add drop
by drop the solution of iodine (0.1 M in THF/pyridine/H2O
78 : 20 : 2/mL). The resulting mixture was stirred for 0.5 h at
0 ◦C, and after addition of ethyl acetate (20 mL), washed with
a saturated solution of sodium thiosulfate. The organic layer
was dried over anhydrous sodium sulfate and the solvent was
removed under reduced pressure. The crude product (551 mg)
was dissolved in a solution of DCA 3.5% in DCM (10 mL), and
was stirred for 0.5 h at RT. The reaction mixture was washed
with a saturated solution of sodium hydrogen carbonate until
the aqueous layer became neutral. The organic layer was dried
over anhydrous sodium sulfate and the solvent was removed
under reduced pressure. The crude product was purified by flash
column chromatography over silica gel using dichloromethane and
methanol (0 to 10%) as eluant to give the title compound as a
yellow oil (53%).
Rf 0.50 (DCM, MeOH, 95 : 5);1H NMR: d 9.71 (1H, br s, NH),
7.55 (1H, s, H6), 6.24 (1H, t, 3J 7.2, H1¢), 5.17 (1H, br s, H3¢), 4.35–
4.10 (7H, m, H4¢, OCH2 iso, 2 ¥ POCH2), 3.88 (1H, br s, H5¢),
3.76 (1H, br s, OH), 3.56 (2H, t, 3J 5.6, OCH
¯ 2¯
CH2), 2.82 (2H, t, 3J
5.6, CH2CN), 2.60–2.35 (3H, m, H2¢, C≡CH), 1.90 (3H, s, CH3),
1.86–1.63 (4H, m, OCH2CH¯ 2¯
CH
¯ 2¯
CH2O);13C NMR: d 164.1(C2),
150.6 (C4), 136.5 (C6), 116.7 (C≡N), 111.3 (C5), 85.8 (C1¢), 85.7
(C4¢), 79.8 (C≡CH), 78.4 (C3¢), 74.5 (C≡CH), 69.2 (OCH2CH2),
68.7 (POCH2), 62.3 (POCH2), 61.8 (C5¢), 58.1 (OCH2 iso), 38.5
(C2¢), 27.2 (OCH2CH2CH2CH2O), 25.4 (OCH2CH2CH2CH2O),
19.7 (CH2C≡N), 12.5 (CH3); 31P NMR: d -2.6; HRMS (ESI):
m/z C20H28KN3O9P requires 524.1195 [M+K]+, found 524.1196
(0.27 ppm).
3¢-Thymidylic acid, 2-cyanoethyl 4-[[(3-phenylisoxazole-5-
yl)methyl]oxy]butyl ester 21
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane and methanol (0 to
5%), to give the title compound as a yellow oil (77%).
Rf 0.54 (DCM, MeOH, 95 : 5); 1H NMR: d 9.45 (1H, br s, NH),
7.82-7.75 (2H, m, ArH), 7.51 (1H, s, H6), 7.48–7.41 (3H, m, ArH),
6.58 (1H, s, CH=CO iso), 6.22 (1H, t, 3J 7.5, H1¢), 5.19–5.12 (1H,
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m, H3¢), 4.63 (2H, m, OCH2 iso), 4.33–4.11 (5H, m, H4¢, 2 ¥
POCH2), 3.87 (2H, br s, H5¢), 3.61 (2H, t, 3J 6.0, OCH¯ 2¯
CH2), 2.78
(2H, t, 3J 6.0, CH2CN), 2.59–2.40 (2H, m, H2¢), 2.17 (1H, br s,
OH), 1.92–1.69 (7H, m, CH3, OCH2CH¯ 2¯
CH
¯ 2¯
CH2O);13C NMR: d
169.8 (C=N iso), 163.9(C2), 162.5 (CO=CH), 150.5 (C4), 136.5
(C6), 130.2 (ArCH), 129.0 (ArCH), 128.8 (ArC), 126.8 (ArCH),
116.6 (C≡N), 111.3 (C5), 101.2 (CH=CO iso), 86.0 (C1¢), 85.6
(C4¢), 78.4 (C3¢), 70.5 (OCH2CH2), 68.7 (POCH2), 63.7 (OCH2 iso),
62.2 (POCH2), 62.0 (C5¢), 38.4 (C2¢), 27.2 (OCH2CH2CH2CH2O),
25.6 (OCH2CH2CH2CH2O), 19.8 (CH2C≡N), 12.5 (CH3); 31P
NMR: d -2.5; HRMS (ESI):m/zC27H35N4O10P requires 303.1040
[M+2H]2+, found 303.1041 (0.46 ppm).
3¢-Thymidylic acid, 2-cyanoethyl 4-[[3-[(1-naphthyl)isoxazole-5-
yl]methyl]oxy]butyl ester 22
The crude product was purified by flash column chromatography
over silica gel, eluting with dichloromethane and methanol (0 to
5%), to give the title compound as a yellow oil (72%).
Rf 0.57 (DCM, MeOH, 95 : 5); 1H NMR: d 8.91 (1H, br s,
NH), 8.38–8.31 (1H, m, ArH), 7.99–7.88 (2H, m, ArH), 7.73–7.67
(1H, m, ArH), 7.59–7.50 (3H, m, ArH), 7.43 (1H, s, H6), 6.59
(1H, s, CH=CO iso), 6.19 (1H, t, 3J 7.2, H1¢), 5.19–5.11 (1H,
m, H3¢), 4.71 (2H, m, OCH2 iso), 4.34–4.13 (5H, m, H4¢, 2 ¥
POCH2), 3.88 (2H, br s, H5¢), 3.67 (2H, t, 3J 6.0, OCH¯ 2¯
CH2),
3.18 (1H, br s, OH), 2.77 (2H, t, 3J 6.0, CH2CN), 2.58–2.40
(2H, m, H2¢), 1.95–1.70 (7H, m, CH3, OCH2CH¯ 2¯
CH
¯ 2¯
CH2O);13C
NMR: d 169.1 (C=N iso), 163.6 (C2), 162.6 (CO=CH), 150.4
(C4), 136.5 (C6), [130.9, 130.4, 128.6, 127.8, 127.1, 126.6, 126.4,
125.5, 125.2] (ArC), 116.6 (C≡N), 111.3 (C5), 104.5 (CH=CO
iso), 86.2 (C1¢), 85.6 (C4¢), 78.3 (C3¢), 70.6 (OCH2CH2), 68.6
(POCH2), 63.7 (OCH2 iso), 62.2 (POCH2), 62.0 (C5¢), 38.4
(C2¢), 27.2 (OCH2CH2CH2CH2O), 25.6 (OCH2CH2CH2CH2O),
19.8 (CH2C≡N), 12.5 (CH3); 31P NMR: d -2.4; HRMS (ESI):
m/z C31H37N4O10P requires 328.1118 [M+2H]2+, found 328.1119
(0.40 ppm).
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